Anika Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon, and thanks for joining us for Anika Therapeutics fireside chat. Joining me today is Cheryl Blanchard, CEO; and Mike Levitz, CFO. Before we get started, let me get rid of the required disclosures. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Great. With that behind us, and obviously, the portal is open for any questions you all may have. Let's get started.
Questions & Answers
Cheryl, I thought maybe we get started. Before we into details, maybe talk a little bit about Anika, who Anika is for those who are not as familiar with the story?
Yes, absolutely. Thanks, Peter, and thanks for the invitation to allow us to continue to tell
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |